news aggregator

Half a century ago, thousands of pregnant women in 46 countries took a drug for morning sickness that would later be discovered to cause severe malformations in developing fetuses. Worldwide, roughly 10,000 affected children nicknamed "thalidomide babies" were born with multiple defects, including the characteristic shortened upper limbs (a condition known as phocomelia, Greek for "seal limbs"), before the drug was discontinued in 1961 after four years on the market.

An electric insulator, in the simplest terms, blocks the flow of electric current. So it would be a bit counterintuitive, to say the least, if a current on one side of an insulator could produce voltage on the other. [More]

Dear EarthTalk: I have a new linoleum floor, which I chose partly for its ecofriendliness. How do I clean and maintain it without using harsh or toxic chemicals? --A. J. Maimbourg, via e-mail

Think arranged marriages are loveless? Not so, says psychologist Robert Epstein, a contributing editor for Scientific American Mind magazine. He spoke March 10 at the 92nd Street Y’s Tribeca site in New York City:

“And there’s even a study published in India [Usha Gupta and Pushpa Singh of the University of Rajasthan, 1982] but using an American love scale, called the Rubin Love Scale, that compared love in love marriages in India, because they have those, too, to love in arranged marriages. And in this particular study, love in the love marriages starts out very high. And then over time it decreases. That’s what all of our studies show. And in the arranged marriages--and this is true in my work, too--we see the love starting out relatively low. Because in some cases the people barely know each other, sometimes they’ve had a half an hour of contact in total before they got married. And then it increases gradually, surpasses the love in the love marriages at about five years. And 10 years out it’s twice as strong.”

In May 2006 Dwayne Berg woke up on a gurney in a Seattle emergency room, an IV in his arm and a team of doctors and nurses working him up. The last thing the 42-year-old financial executive could remember was running on a treadmill at his gym, part of his regular fitness regimen. He had suffered a seizure and tumbled off the machine, and although he had not hurt himself in the fall, doctors had asked for an MRI scan of his brain to see if they could find a cause for the seizure.

They did, and the news was not good: the scan showed a large mass in the left frontal lobe that turned out to be a malignant glioma, a brain cancer that is almost invariably fatal. Berg underwent standard treatment: an operation to remove the tumor, followed by chemotherapy and radiation to eradicate any cancer cells that might remain.

Imagine suffering from the crushing weight of major depression, then finally getting diagnosed and starting treatment with a drug--only to realize after two months that the medication, despite its unpleasant side effects, is not alleviating your depression. Unfortunately, this experience is far from rare: more than two thirds of patients with depression have no luck with the first medication they are prescribed and must also endure the withdrawal effects that come with discontinuing a drug before trying a new one. Finding the right treatment can prove a lengthy, painful process of trial and error. A new technology, however, may bypass this ordeal by gauging very early in a treatment regimen how well a drug is working based on the patient’s brain waves.

The technology, called quantitative electro­enceph­alography (QEEG), measures a person’s brain-wave pattern with EEG and then compares it with a database of normal samples to detect abnormal function. In a study published in the September 2009 issue of the journal Psychiatry Research , scientists used QEEG to record brain activity in subjects with major depressive disorder before they began treatment, after one week on an antidepressant and after eight weeks on the drug--the period it takes such drugs to achieve full effect. Changes in the QEEG readout after just one week of medication predicted 74 percent of the time whether patients would experience either a recovery or a remission of symptoms by the end of eight weeks.

MIAMI--Malaria continues to be a global scourge, sickening some 300 million to 500 million people annually. Most of the resulting one million to three million malaria deaths occur in regions where it is highly endemic, such as sub-Saharan Africa and parts of south Asia.  [More]